DMII vs PRTH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DMII · DRUGS MADE IN AMERICA ACQ II CORP$10.21 ▼ 0.10%
PRTH · Priority Technology$7.88 ▲ 0.13%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DMII +3.3%
- PRTH +36.3%
Head to head
| Metric | DMII | PRTH |
|---|---|---|
| Price | $10.21 | $7.88 |
| Change today | ▼ 0.10% | ▲ 0.13% |
| Market cap | $650.38M | $650.68M |
| Return, 3 months | +0.9% | +50.7% |
| Return, year to date | +3.1% | +44.6% |
| Return, 1 year | – | +61.8% |
| P/E (TTM) | 35.0 | 16.4 |
| P/B | 1.3 | -9.9 |
| P/E percentile vs own 5y | 63rd | 94th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +9.4% |
| Net profit growth (YoY) | +11,647.4% | -9.3% |
| Gross margin | – | 39.4% |
| Operating margin | – | 13.8% |
| Net margin | – | 5.6% |
| Return on equity | 5.3% | – |
| Analyst target vs. price | – | -0.8% |
| Analyst buy share | – | 20% |
| RSI (14) | 62 | 73 |
| 30-day volatility | 0.9% | 3.8% |
| Max drawdown, 1 year | -0.7% | -37.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PRTH is the largest of the group by market value.
- PRTH carries the lowest trailing P/E.
- DMII has been the calmest stock over the last 30 days.